Aviceda to Advance GA Drug into Phase III Trials Despite Phase IIb Primary Endpoint Miss
Lesions aside, functional vision keeps AVD-104 in the GA therapy race. In geographic atrophy (GA) drug development, a missed primary…
latest posts
Lesions aside, functional vision keeps AVD-104 in the GA therapy race. In geographic atrophy (GA) drug development, a missed primary…